Christine M. Fisher, MD, MPH

home / authors / christine-m-fisher-md-mph

Articles

Treatment Disparities in Locally Advanced Cervical Cancer Impact Survival

January 17th 2017

In this interview we discuss a recent study that found that more than half of patients with locally advanced cervical cancer in the United States did not receive standard of care.

Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies

Linda Overholser, MD, MPH;Elena Shagisultanova, MD, PhD;Rachel Rabinovitch, MD;Nicole Kounalakis, MD;Jennifer Diamond, MD;Christina A. Finlayson, MD;Christine M. Fisher, MD, MPH;Peter Kabos, MD;Anthony D. Elias, MD;Virginia F. Borges, MD, MMSc;Jose Mayordomo, MD, PhD

December 15th 2016

We review available strategies for screening and risk reduction through chemoprevention or risk-reducing surgery, as well as challenges for management of breast cancer in patients with prior exposure to radiation for Hodgkin lymphoma.

Multiple Hepatic Lesions in a Patient With a History of DCIS

Jagar Jasem, MD, MPH;Basel Altoos, BS;Christine M. Fisher, MD, MPH;Anthony D. Elias, MD;Nicole Kounalakis, MD;Virginia F. Borges, MD, MMSc;Peter Kabos, MD

September 15th 2015

An asymptomatic 45-year-old woman presented for a screening mammogram and was noted to have a soft-tissue opacity with calcifications in the left breast. Ultrasound revealed a highly suspicious mass.

Management of Young Breast Cancer Patients With de Novo Genetic Mutations

Christine M. Fisher, MD, MPH;Catherine E. Klein, MD;Laxmi A. Kondapalli, MD, MSCE;Anthony D. Elias, MD;Virginia F. Borges, MD, MMSc

October 15th 2014

A 24-year-old woman presents to her primary care provider with a mass in her left breast. Examination confirms a 2.2-cm mass in the upper outer quadrant, with a single mobile axillary node that is firm to palpation.

Pelvic Radiation Therapy for Early Endometrial Cancer: Careful Selection Is Key

Christine M. Fisher, MD, MPH;Tracey E. Schefter, MD

October 15th 2013

Future directions, including nomograms, multi-modality approaches, and more individualized patient care based on genomic profiles, may help to tailor each endometrial cancer patient’s therapy to her individual risk.